Novo Nordisk launched the product in the United States in January 2026, marking the first time an oral GLP-1 treatment had been cleared specifically for weight management
Lets have a closer look at direct and as cross trials of semaglutide versus dulaglutide: Blood sugar control (A1c reduction) In an open-label SUSTAIN 7 clinical trial published in The Lancet, 1,201 patients were divided into four subgroups: semaglutide 0.5 mg (301 patients), semaglutide 1.0 mg (300 patients), dulaglutide 0.75 mg (299 patients), and dulaglutide 1.5 mg (299 patients)
And it shows no signs of letting up
Step 1: Wash your hands Same standard as pen injections
That means that drinking coffee (or consuming other sources of caffeine, such as tea, soft drinks, or matcha) will not prevent Mounjaro from doing its job of lowering blood sugar
Notably, many patients experience beneficial effects on their blood sugar levels, which is especially important for individuals with type 2 diabetes